Thursday January 18, 2018
Saturday January 20, 2018
Thursday January 18, 2018
13:00
- 14:00
FUTURE LEADERS MENTORING: WARMING UP
Chairs: S. Aliberti, J. Chalmers
> Session dedicated to a preselected group of German Interns in Respiratory Medicine
14:00
- 15:00
RISING STAR SESSION
Chairs: F. Blasi, G.W. Canonica, S. Centanni, J.C. Virchow
14.00 – 14.15 Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks
Isis E. Fernandez (Colombia)
14.30 – 14.45 Assessing inflammatory patterns in asthma endotypes; new diagnostic and therapeutic perspectives
>Matteo Bradicich (Italy)
> Each lecture will be followed by 10’ question time and 5’ of comments and advices by the Chairmen.
15:00
- 15:40
OPENING LECTURE
Chair: F. Blasi (Italy)
> Personalised medicine: how far are we?
Peter Barnes (United Kingdom)
15:40
- 16:40
INDUSTRY SPONSORED SYMPOSIUM
16:40
- 17:10
COFFEE BREAK
17:10
- 18:40
Session I • Bronchiectasis: is phenotyping useful for guiding the management?
Chairs: F. Blasi (Italy), F. C. Ringshausen (Germany)
|
|
|
17.10 - 17.35 |
Alpha1-antitrypsin deficiency: can we make the difference? |
Timm Greulich
(Germany) |
17.35 - 18.00 |
Imaging, pulmonary function testing, LCI and what else? |
Stefano Aliberti
(Italy) |
18.00 - 18.25 |
Severity scores in the real life management of bronchiectasis. |
James D. Chalmers
(UK) |
18.25 - 18.40 |
Discussion |
|
18:40
- 19:10
KEYNOTE LECTURE
Chair: S. Aliberti (Italy)
Non tuberculous mycobacteria (NTM): state-of-the art
Michael Loebinger (United Kingdom)
19:10
- 19:50
NATIONAL SOCIETY SESSION
Chairs : F. Blasi, G. W. Canonica
>Respiratory research in Germany – Interventional options
Felix Herth (Germany)
19:50
- 20:30
WELCOME COCKTAIL
08:30
- 09:10
KEYNOTE LECTURE
Chair: F. Blasi (Italy)
> Can we really have a personalised therapy in Asthma?
J. C. Virchow (Germany)
09:10
- 10:40
SESSION II • New biomarkers, new drugs, new management
Chairs: F. Braido (Italy) and N. Roche (France)
|
|
|
09.10 - 09.35 |
Lung Cancer(s) |
David Heigener (Germany) |
09.35 – 10.00 |
IPF - Idiopathic Pulmonary Fibrosis |
Fabrizio Luppi (Italy) |
10.00 - 10.25 |
Allergy and Asthma |
Leif Bjermer (Sweden) |
10.25 - 10.40 |
Discussion |
|
10:40
- 11:10
COFFEE BREAK
11:10
- 12:30
SESSION III • Pros and Cons in upper respiratory tract allergy & asthma immunotherapy
Chairs : G. W. Canonica (Italy), D. Ryan (UK)
|
|
|
11.10- 11.30 |
PROs |
Johann Christian Virchow (Germany) |
11.30 - 11.50 |
CONs |
Pierluigi Paggiaro (Italy) |
11.50 - 12.00 |
Rebuttal PROs |
|
12.00 - 12.10 |
Rebuttal CONs |
|
12.10 - 12.30 |
Discussion |
|
Interactive session with voting tools
Chair: G.W. Canonica (Italy)
Electronic Device efficacy in management of asthma patients
Fulvio Braido (Italy)
14:00
- 14:40
SESSION IV: COPD IN YEAR REVIEW
Chair: P. Santus (Italy)
COPD in Year Review
Antoni Torres (Spain)
14.30 – 14.40 Discussion
14:40
- 15:10
INDUSTRY SPONSORED LECTURE*
Chair: G. W. Canonica (Italy)
Including Immunotherapy into Precision Medicine in Asthma
Johann Christian Virchow (Germany)
15:40
- 16:10
COFFEE BREAK
16:10
- 17:40
SESSION V: IMAGING GROUND ROUND
Chairs: M. Pistolesi (Italy), T. Welte (Germany)
Discussion of 4-5 cases (e.g. pulmonary embolism, emphysema, rare diseases, bronchiectasis, fungal infection and chronic sinusitis)
Nicola Sverzellati (Italy), Jens Vogel-Claussen (Germany)
Interactive session with voting tools
17:40
- 18:45
STROLLING POSTER SESSION
Chairs: F. Blasi, G.W. Canonica, S. Centanni, J. C. Virchow, T. Welte
Saturday January 20, 2018
09:00
- 09:30
KEYNOTE LECTURE
Chair: M. Cazzola (Italy)
Evidence based knowledge: the role of real life studies
Giovanni Sotgiu (Italy)
09:30
- 10:10
SESSION VI : Asthma in Year Review
Chair: T. Welte (Germany)
Asthma in Year Review
Guy Brusselle (Belgium)
10.00 – 10.10 Discussion
10:10
- 10:40
COFFEE BREAK
10:40
- 12:00
SESSION VII • Phenotyping is still a target for personalised COPD management
Chairs: J. C. Virchow (Germany), N. Roche (France)
|
|
|
10.40 - 11.00 |
PROs |
Jose Luis Lopez-Campos (Spain) |
11.00 - 11.20 |
CONs |
Stefano Centanni (Italy) |
11.20 - 11.30 |
Rebuttal PROs |
|
11.30 - 11.40 |
Rebuttal CONs |
|
11.40-12.00 |
Discussion |
|
Interactive session with voting tools
12:00
- 12:40
KEYNOTE LECTURE
Chair: F. di Marco (Italy)
> Stable COPD Treatment : Where Are We?
Nicolas Roche (France)
12:40
- 13:00
POSTER AWARDS AND CLOSING REMARKS
Chairs: F. Blasi, G.W. Canonica, S. Centanni, J. C. Virchow, T. Welte
13:00
- 14:00
FUTURE LEADERS MENTORING: REPORT and FEEDBACK
Chairs: S. Aliberti, J. D. Chalmers
Session dedicated to a preselected group of German Interns in Respiratory Medicine where they will report on the outcome of their mentoring programme. Session open to all participants.
Thursday, 18 January 2018
15:40
- 16:40
SPONSORED SESSION – Thursday, 18 January 2018
DISCLAIMER: THE FOLLOWING LECTURES ARE ORGANIZED BY INDUSTRY.
YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THESE SESSIONS
15.40 – 16.40 |
THE GAP BETWEEN DESIRE AND BRONCHIECTASIS MANAGEMENT SYMPOSIUM ORGANISED BY GRIFOLS
Chair: M. Loebinger (United Kingdom)
|
15:40 – 15.45 |
Welcome & Introduction
Michael Loebinger (United Kingdom)
|
15:45 – 16.05 |
How should patients be managed according to the new ERS Bronchiectasis Guidelines?
Eva Polverino (Spain)
|
16.05 – 16.25 |
How do clinical studies and the bronchiectasis registry reflect reality?
Felix Ringshausen (Germany)
|
16.25 – 16.40 |
Live Voting Summary & Discussion
Interactive session with voting tools
|
19:15
- 20:30
SPONSORED SESSION – Friday, 19 January 2018
DISCLAIMER: THE FOLLOWING LECTURES ARE ORGANIZED BY INDUSTRY.
YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THESE SESSIONS
14.40 – 15.10 |
LECTURE
ORGANISED BY MENARINI GROUP
Better understanding leads to better treatment of COPD
Dave Singh (United Kingdom) |
INDUSTRY SPONSORED SATELLITE SYMPOSIUM |
19.15 – 20.30 |
SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM
ORGANISED BY BOEHRINGER INGELHEIM
|
|
Session I:
Chairs: G.W. Canonica (Italy), S. Centanni (Italy) |
19.15 – 19.30 |
The double bronchodilatation rationale in COPD Therapy
Pier Achille Santus (Italy) |
19.30 – 19.45 |
LAMA & Asthma : which indications?
Nicola Scichilone (Italy) |
19.45 – 20.00 |
Device Role in Therapy Management
Fabiano Di Marco (Italy) |
|
Session II:
Chairs: F. Blasi (Italy) |
20.00 – 20.15 |
IPF management in light of new therapeutic options
Fabrizio Luppi (Italy) |
20.15 – 20.30 |
Questions & Answers |
Thursday, 18 January 2018
FUTURE LEADERS MENTORING: WARMING UP
Chairs: S. Aliberti, J. Chalmers
> Session dedicated to a preselected group of German Interns in Respiratory Medicine
Chairs: F. Blasi, G.W. Canonica, S. Centanni, J.C. Virchow
14.00 – 14.15 Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks
Isis E. Fernandez (Colombia)
14.30 – 14.45 Assessing inflammatory patterns in asthma endotypes; new diagnostic and therapeutic perspectives
>Matteo Bradicich (Italy)
> Each lecture will be followed by 10’ question time and 5’ of comments and advices by the Chairmen.
Chair: F. Blasi (Italy)
> Personalised medicine: how far are we?
Peter Barnes (United Kingdom)
INDUSTRY SPONSORED SYMPOSIUM
Session I • Bronchiectasis: is phenotyping useful for guiding the management?
Chairs: F. Blasi (Italy), F. C. Ringshausen (Germany)
|
|
|
17.10 - 17.35 |
Alpha1-antitrypsin deficiency: can we make the difference? |
Timm Greulich
(Germany) |
17.35 - 18.00 |
Imaging, pulmonary function testing, LCI and what else? |
Stefano Aliberti
(Italy) |
18.00 - 18.25 |
Severity scores in the real life management of bronchiectasis. |
James D. Chalmers
(UK) |
18.25 - 18.40 |
Discussion |
|
Chair: S. Aliberti (Italy)
Non tuberculous mycobacteria (NTM): state-of-the art
Michael Loebinger (United Kingdom)
Chairs : F. Blasi, G. W. Canonica
>Respiratory research in Germany – Interventional options
Felix Herth (Germany)
Chair: F. Blasi (Italy)
> Can we really have a personalised therapy in Asthma?
J. C. Virchow (Germany)
SESSION II • New biomarkers, new drugs, new management
Chairs: F. Braido (Italy) and N. Roche (France)
|
|
|
09.10 - 09.35 |
Lung Cancer(s) |
David Heigener (Germany) |
09.35 – 10.00 |
IPF - Idiopathic Pulmonary Fibrosis |
Fabrizio Luppi (Italy) |
10.00 - 10.25 |
Allergy and Asthma |
Leif Bjermer (Sweden) |
10.25 - 10.40 |
Discussion |
|
SESSION III • Pros and Cons in upper respiratory tract allergy & asthma immunotherapy
Chairs : G. W. Canonica (Italy), D. Ryan (UK)
|
|
|
11.10- 11.30 |
PROs |
Johann Christian Virchow (Germany) |
11.30 - 11.50 |
CONs |
Pierluigi Paggiaro (Italy) |
11.50 - 12.00 |
Rebuttal PROs |
|
12.00 - 12.10 |
Rebuttal CONs |
|
12.10 - 12.30 |
Discussion |
|
Interactive session with voting tools
Chair: G.W. Canonica (Italy)
Electronic Device efficacy in management of asthma patients
Fulvio Braido (Italy)
SESSION IV: COPD IN YEAR REVIEW
Chair: P. Santus (Italy)
COPD in Year Review
Antoni Torres (Spain)
14.30 – 14.40 Discussion
INDUSTRY SPONSORED LECTURE*
Chair: G. W. Canonica (Italy)
Including Immunotherapy into Precision Medicine in Asthma
Johann Christian Virchow (Germany)
SESSION V: IMAGING GROUND ROUND
Chairs: M. Pistolesi (Italy), T. Welte (Germany)
Discussion of 4-5 cases (e.g. pulmonary embolism, emphysema, rare diseases, bronchiectasis, fungal infection and chronic sinusitis)
Nicola Sverzellati (Italy), Jens Vogel-Claussen (Germany)
Interactive session with voting tools
Chairs: F. Blasi, G.W. Canonica, S. Centanni, J. C. Virchow, T. Welte
Chair: M. Cazzola (Italy)
Evidence based knowledge: the role of real life studies
Giovanni Sotgiu (Italy)
SESSION VI : Asthma in Year Review
Chair: T. Welte (Germany)
Asthma in Year Review
Guy Brusselle (Belgium)
10.00 – 10.10 Discussion
SESSION VII • Phenotyping is still a target for personalised COPD management
Chairs: J. C. Virchow (Germany), N. Roche (France)
|
|
|
10.40 - 11.00 |
PROs |
Jose Luis Lopez-Campos (Spain) |
11.00 - 11.20 |
CONs |
Stefano Centanni (Italy) |
11.20 - 11.30 |
Rebuttal PROs |
|
11.30 - 11.40 |
Rebuttal CONs |
|
11.40-12.00 |
Discussion |
|
Interactive session with voting tools
Chair: F. di Marco (Italy)
> Stable COPD Treatment : Where Are We?
Nicolas Roche (France)
POSTER AWARDS AND CLOSING REMARKS
Chairs: F. Blasi, G.W. Canonica, S. Centanni, J. C. Virchow, T. Welte
FUTURE LEADERS MENTORING: REPORT and FEEDBACK
Chairs: S. Aliberti, J. D. Chalmers
Session dedicated to a preselected group of German Interns in Respiratory Medicine where they will report on the outcome of their mentoring programme. Session open to all participants.
SPONSORED SESSION – Thursday, 18 January 2018
DISCLAIMER: THE FOLLOWING LECTURES ARE ORGANIZED BY INDUSTRY.
YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THESE SESSIONS
15.40 – 16.40 |
THE GAP BETWEEN DESIRE AND BRONCHIECTASIS MANAGEMENT SYMPOSIUM ORGANISED BY GRIFOLS
Chair: M. Loebinger (United Kingdom)
|
15:40 – 15.45 |
Welcome & Introduction
Michael Loebinger (United Kingdom)
|
15:45 – 16.05 |
How should patients be managed according to the new ERS Bronchiectasis Guidelines?
Eva Polverino (Spain)
|
16.05 – 16.25 |
How do clinical studies and the bronchiectasis registry reflect reality?
Felix Ringshausen (Germany)
|
16.25 – 16.40 |
Live Voting Summary & Discussion
Interactive session with voting tools
|
SPONSORED SESSION – Friday, 19 January 2018
DISCLAIMER: THE FOLLOWING LECTURES ARE ORGANIZED BY INDUSTRY.
YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THESE SESSIONS
14.40 – 15.10 |
LECTURE
ORGANISED BY MENARINI GROUP
Better understanding leads to better treatment of COPD
Dave Singh (United Kingdom) |
INDUSTRY SPONSORED SATELLITE SYMPOSIUM |
19.15 – 20.30 |
SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM
ORGANISED BY BOEHRINGER INGELHEIM
|
|
Session I:
Chairs: G.W. Canonica (Italy), S. Centanni (Italy) |
19.15 – 19.30 |
The double bronchodilatation rationale in COPD Therapy
Pier Achille Santus (Italy) |
19.30 – 19.45 |
LAMA & Asthma : which indications?
Nicola Scichilone (Italy) |
19.45 – 20.00 |
Device Role in Therapy Management
Fabiano Di Marco (Italy) |
|
Session II:
Chairs: F. Blasi (Italy) |
20.00 – 20.15 |
IPF management in light of new therapeutic options
Fabrizio Luppi (Italy) |
20.15 – 20.30 |
Questions & Answers |
Select date to see events.